Literature DB >> 3156871

Evidence for adrenocortical adaptation to severe illness.

L N Parker, E R Levin, E T Lifrak.   

Abstract

During serious illness, there are characteristic increases in serum cortisol concentrations and urinary cortisol excretion. In the present studies, we investigated these changes in glucocorticoid metabolism in relation to adrenal androgen metabolism, as measured by RIA of dehydroepiandrosterone (DHA) and DHA sulfate (DHAS). A group of 23 seriously ill men with various disorders, ill for a week or longer, was age-matched to a control group of 25 men, and the following changes were found: 1) basal serum cortisol concentrations were elevated in the ill group (P less than 0.001), 2) basal serum DHA and DHAS concentrations tended to be lower in the ill group (P less than 0.1); 3) basal serum DHA to cortisol and DHAS to cortisol ratios were decreased in the ill group by 80.3% and 77.2%, respectively (P less than 0.001); 4) ACTH-stimulated serum cortisol concentrations increased by the same absolute amount in both groups, whereas the increase in stimulated DHA concentrations in the ill group was 57.2% less (P less than 0.05), indicating a defect in ACTH-stimulated DHA reserve in serious illness; 5) basal daily unconjugated DHA excretion was lower in the ill group (P less than 0.05); (6) basal daily cortisol excretion was higher in the ill group (P less than 0.05); and 7) the basal daily urinary unconjugated DHA to cortisol ratio was 85.4% lower in the ill group (P less than 0.001). Recently, Zipser et al. described the entity of hyperreninemic hypoaldosteronism in the seriously ill. Their findings combined with our own indicate a relative shift in the metabolism of adrenal pregnenolone in serious illness away from mineralocorticoids and adrenal androgens and toward glucocorticoids. The cause of this change is unknown. We speculate that this shift of relative biochemical pathway predominance may be a factor necessary for survival during chronic severe stress.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156871     DOI: 10.1210/jcem-60-5-947

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  [Cortisone substitution in sepsis. Is less more?].

Authors:  J Briegel
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

3.  Cortisol, dehydroepiandrosterone sulphate and dehydroepiandrosterone sulphate/cortisol ratio responses to physical stress in males are influenced by pubertal development.

Authors:  L Di Luigi; L Guidetti; C Baldari; M C Gallotta; P Sgrò; F Perroni; F Romanelli; A Lenzi
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 4.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Endocrine mechanisms of stress-induced DHEA-secretion.

Authors:  R Oberbeck; R J Benschop; R Jacobs; W Hosch; J U Jetschmann; T H Schürmeyer; R E Schmidt; M Schedlowski
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

Review 6.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

7.  Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study.

Authors:  O Malkesman; T Asaf; L Shbiro; A Goldstein; R Maayan; A Weizman; N Kinor; E Okun; B Sredni; G Yadid; A Weller
Journal:  Adv Pharmacol Sci       Date:  2009-10-18

Review 8.  The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma.

Authors:  Yvonne Christley; Tim Duffy; Ian Paul Everall; Colin R Martin
Journal:  Curr Psychiatry Rep       Date:  2013-04       Impact factor: 5.285

Review 9.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.